Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum

The human body employs different DNA repair pathways to protect itself against cancers induced by DNA damage. The nucleotide excision repair (NER) pathway comprises different synchronously working DNA repair proteins; two of which are XPA and XPC. Mutations of any of the genes encoding the NER prote...

Full description

Saved in:
Bibliographic Details
Main Author: Rabie, Eman AbdelAlim Sidky
Format: Thesis
Published: AUC Knowledge Fountain 2016
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613420802539520
access_status_str Open Access
author Rabie, Eman AbdelAlim Sidky
author_browse Rabie, Eman AbdelAlim Sidky
author_facet Rabie, Eman AbdelAlim Sidky
author_sort Rabie, Eman AbdelAlim Sidky
collection Thesis
description The human body employs different DNA repair pathways to protect itself against cancers induced by DNA damage. The nucleotide excision repair (NER) pathway comprises different synchronously working DNA repair proteins; two of which are XPA and XPC. Mutations of any of the genes encoding the NER proteins cause an autosomal recessive genetic disorder called Xeroderma Pigmentosum (XP). XP patients present with characteristic dry atrophic freckle-like pigmentation of the skin, photosensitivity and photophobia. Some patients develop neurodegenerative symptoms early in life, including mental retardation. Patients have a 10,000-fold increased risk for UV-induced skin cancers, moreover, a higher risk for ocular, oral and internal cancers. Death usually results from skin cancers, neurological deterioration, and internal cancers. XP is a rare disorder; it affects one per million individuals, however, higher incidences were observed in some geographical areas such as Mayotte islands (1:5000), Japan (1:22,000) and North Africa (1:10,000 in Tunisia and 1:80,504 in Morocco) due to geographical isolation, and high rate of intra-familial marriage. In North Africa, and in Egypt, XPC followed by XPA gene mutations are the most common. In Egypt, XP accounts for 15.9% of genetic skin disorders. Recently, XPA gene mutations were detected in four Egyptian XP patients only. In the current study, fourteen unrelated families having seventeen XP Egyptian patients were studied via direct sequencing for detection of both XPA and XPC gene mutations. This is the first study to identify mutations in both XPA and XPC genes in Egyptian XP patients with variable clinical features. Ten mutations were identified; four of which were recurrent mutations, three were novel mutations, and three mutations were reported previously in non-Egyptian XP patients. Carrier and prenatal screening were provided for the studied families. Spectra of XPA and XPC mutations in the Egyptian population were outlined with emphasis on clinical phenotypes. In conclusion, identification of pathogenic mutations provided a valuable tool for detection of recurring and private XP mutations in the Egyptian population. Mutation detection augments genetic counseling via carrier, prenatal and premarital screening, and provides a cornerstone for development of diagnostic strategies and future gene therapies.
format Thesis
id oai:fount.aucegypt.edu:etds-2820
institution American University in Cairo (Egypt)
last_indexed 2026-06-10T12:35:51.500Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from AUC Knowledge Fountain — bepress
publishDate 2016
publishDateRange 2016
publishDateSort 2016
publisher AUC Knowledge Fountain
publisherStr AUC Knowledge Fountain
record_format dspace
source_str AUC Knowledge Fountain — bepress
spelling oai:fount.aucegypt.edu:etds-2820 Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum Rabie, Eman AbdelAlim Sidky The human body employs different DNA repair pathways to protect itself against cancers induced by DNA damage. The nucleotide excision repair (NER) pathway comprises different synchronously working DNA repair proteins; two of which are XPA and XPC. Mutations of any of the genes encoding the NER proteins cause an autosomal recessive genetic disorder called Xeroderma Pigmentosum (XP). XP patients present with characteristic dry atrophic freckle-like pigmentation of the skin, photosensitivity and photophobia. Some patients develop neurodegenerative symptoms early in life, including mental retardation. Patients have a 10,000-fold increased risk for UV-induced skin cancers, moreover, a higher risk for ocular, oral and internal cancers. Death usually results from skin cancers, neurological deterioration, and internal cancers. XP is a rare disorder; it affects one per million individuals, however, higher incidences were observed in some geographical areas such as Mayotte islands (1:5000), Japan (1:22,000) and North Africa (1:10,000 in Tunisia and 1:80,504 in Morocco) due to geographical isolation, and high rate of intra-familial marriage. In North Africa, and in Egypt, XPC followed by XPA gene mutations are the most common. In Egypt, XP accounts for 15.9% of genetic skin disorders. Recently, XPA gene mutations were detected in four Egyptian XP patients only. In the current study, fourteen unrelated families having seventeen XP Egyptian patients were studied via direct sequencing for detection of both XPA and XPC gene mutations. This is the first study to identify mutations in both XPA and XPC genes in Egyptian XP patients with variable clinical features. Ten mutations were identified; four of which were recurrent mutations, three were novel mutations, and three mutations were reported previously in non-Egyptian XP patients. Carrier and prenatal screening were provided for the studied families. Spectra of XPA and XPC mutations in the Egyptian population were outlined with emphasis on clinical phenotypes. In conclusion, identification of pathogenic mutations provided a valuable tool for detection of recurring and private XP mutations in the Egyptian population. Mutation detection augments genetic counseling via carrier, prenatal and premarital screening, and provides a cornerstone for development of diagnostic strategies and future gene therapies. 2016-05-05T07:00:00Z thesis application/pdf https://fount.aucegypt.edu/etds/1790 https://fount.aucegypt.edu/context/etds/article/2820/viewcontent/Print_XP_thesis_New_2.pdf Theses and Dissertations AUC Knowledge Fountain Xeroderma Pigmentosum Mutations XPA gene Mutation detection Human Genetics Genetics and Genomics Medicine and Health Sciences
spellingShingle Xeroderma Pigmentosum
Mutations
XPA gene
Mutation detection
Human Genetics
Genetics and Genomics
Medicine and Health Sciences
Rabie, Eman AbdelAlim Sidky
Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum
title Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum
title_full Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum
title_fullStr Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum
title_full_unstemmed Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum
title_short Identification of XPA and XPC gene mutations in patients with xeroderma pigmentosum
title_sort identification of xpa and xpc gene mutations in patients with xeroderma pigmentosum
topic Xeroderma Pigmentosum
Mutations
XPA gene
Mutation detection
Human Genetics
Genetics and Genomics
Medicine and Health Sciences
url https://fount.aucegypt.edu/etds/1790
https://fount.aucegypt.edu/context/etds/article/2820/viewcontent/Print_XP_thesis_New_2.pdf
work_keys_str_mv AT rabieemanabdelalimsidky identificationofxpaandxpcgenemutationsinpatientswithxerodermapigmentosum